Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 8/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | TPX2 | Q9ULW0 | 1/20 | 0.44 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.43 |
| ▸ | TDP2 | O95551 | 1/20 | 0.42 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | FPR2 | P25090 | 1/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21389034 | 0.81 | CHRNA7 (0.41) | ADORA3CHRNA7AURKATPX2SCN5A | |
| SCHEMBL7005915 | 0.75 | ABCG2 (0.54) | ADORA3CHRNA7KDM4EMAPT | |
| SCHEMBL7011714 | 0.74 | ADRB3 (0.41) | ADORA3CHRNA7TDP2SCN10APPARD | |
| SCHEMBL22461212 | 0.74 | AURKA (0.44) | ADORA3CHRNA7AURKATPX2SCN5A | |
| SCHEMBL21389027 | 0.73 | ESR1 (0.54) | MAPT | |
| SCHEMBL9060680 | 0.72 | SCN5A (0.48) | ADORA3CHRNA7SCN5ATDP2SCN10A | |
| SCHEMBL17110105 | 0.72 | KIF11 (0.53) | AURKATPX2SCN5ASCN10AKIF11 | |
| SCHEMBL1044896 | 0.72 | KIF11 (0.53) | AURKATPX2SCN5ASCN10AKIF11 | |
| SCHEMBL7708933 | 0.71 | AURKA (0.46) | ADORA3AURKATPX2SCN5AKIF11 | |
| SCHEMBL27675967 | 0.71 | CHRNA7 (0.62) | ADORA3CHRNA7KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11678574-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| US-11678574-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11678574-B2 | Compound and organic light emitting diode comprising same | CYP1A1, ARL1, ALDH1A1 | ADORA3 1587/4885CHRNA7 3323/4885AURKA 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.